Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Baelurlalee

Explore full profile

Global leader in quantitative ultrasound solutions - The world’s first ultrasound technology to quantitatively characterize cell properties from ultrasound radio-frequency signals

Seoul, South KoreaFounded 2021Health Tech & Medtech
Valuation $50–100M Last recorded · 2025
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Baelurlalee and the history behind them.

About Baelurlalee

Barreleye is a South Korean medical technology company, established in 2021, that operates in the diagnostic assistance market. The company was founded by Professor Hyunmin Bae, who also serves as the CEO, leveraging his background as a faculty member in the School of Electrical Engineering and Dean of the KAIST Startup Institute. The firm's technological foundation stems from research that began in a KAIST lab, focusing on applying artificial intelligence to quantitative ultrasound.

Barreleye's business centers on developing and providing AI-powered software solutions that analyze ultrasound signals to quantify cellular and biomechanical tissue characteristics. This technology assists medical professionals in making more informed diagnostic decisions. The company's business model is likely based on licensing its software to hospitals, clinics, and global medical device manufacturers. Barreleye has secured approximately $10 million in a Series A funding round from a strategic global healthcare corporation, adding to earlier seed investments from Mirae Holdings and KAIC To Ventures. This funding is aimed at accelerating global clinical studies, securing regulatory approvals, and moving towards full-scale commercialization.

The company has developed a suite of products for different clinical applications. The Intelligence (Int) series analyzes the biomechanical properties of tissue. 'Int-BUS' is a solution for breast cancer diagnosis that provides a probability of malignancy, which was designated as an innovative medical device in South Korea. 'Int-HUS' measures hepatic fat proportion to aid in the early detection of fatty liver disease. The Vision (Vis) series focuses on image analysis. 'Vis-BUS' provides real-time detection of abnormal lesions in breast ultrasounds, while 'Vis-CUS' is an AI-based tool for assessing cardiac function from echocardiography images. These solutions are designed to work with existing ultrasound equipment, enhancing their diagnostic capabilities without requiring new hardware.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2021
Headquarters
Seoul, South Korea
Employees
13
Open positions
None listed
Dealroom signal
84.1/100
Industry
Health
Sub-industry
Medical Devices
Sector
Health Tech & Medtech, Health Diagnostics, AI for medical imaging
Technology
Artificial Intelligence
Business model
Manufacturing
Client focus
b2b

Funding history

1 recorded event

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES A✓Equity / VC Nov 2025 $12M $47M Undisclosed ↗
Showing the latest 1 of 1 recorded eventsBook a demo for the full funding history →

Growth signals

Baelurlalee website traffic

Latest recorded traffic for Baelurlalee is 3.9K monthly website visits, up 39.3% over the last three months. Baelurlalee's team grew 62.5% over the past year.

Latest monthly visits3.9K 3-month web change+39.3% 1-year team growth+62.5%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

1 investor on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Other known investors1 additional known investor

  • KAIST ILP
Team profiled 2 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇰🇷 South Korea66.7%
🇺🇸 United States16.7%
2 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Baelurlalee on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Baelurlalee’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.